SNF5 promotes cell proliferation and immune evasion in non-small cell lung cancer

Ying Chen1, Meilian Zhao1, Dongliang Shen1

  • 1Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.

Bioengineered
|May 4, 2022
PubMed

Insights

SNF5 promotes Non-Small Cell Lung Cancer (NSCLC) growth and immune evasion by activating the STAT3 pathway. This oncogene presents a potential therapeutic target for NSCLC treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor cells use immune evasion to enhance growth and metastasis.
  • SNF5, a SWI/SNF subunit, is implicated in malignancies, but its role in Non-Small Cell Lung Cancer (NSCLC) immune evasion is unknown.

Purpose of the Study:

  • To investigate the function of SNF5 in NSCLC proliferation and immune evasion.
  • To elucidate the mechanism by which SNF5 regulates immune evasion in NSCLC.

Main Methods:

  • Analyzed SNF5 expression and survival in lung cancer using TCGA database.
  • Performed gain and loss of function experiments in NSCLC cell lines (A549, NCI-H1299) using lentivirus and siRNA.
  • Assessed cell proliferation, immune evasion gene expression, and co-culture with T cells.
  • Explored the STAT3/phospho-STAT3 pathway activation.

Main Results:

  • SNF5 expression is significantly elevated in lung cancer tissues compared to normal tissues.
  • SNF5 overexpression promotes NSCLC cell proliferation and upregulates immune evasion genes.
  • Overexpression of SNF5 reduces NSCLC cell mortality during co-culture with T cells.
  • SNF5 activates the STAT3/phospho-STAT3 pathway, contributing to immune evasion.

Conclusions:

  • SNF5 acts as an oncogene in NSCLC.
  • SNF5 promotes NSCLC progression and immune evasion via the STAT3 pathway.
  • SNF5 represents a promising therapeutic target for NSCLC treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
3.6K